Subtype-specific incidence rates of lymphoid malignancies in Hong Kong compared to the United States, 2001-2010
Subtype-specific incidence rates of lymphoid malignancies in Hong Kong compared to the United States, 2001-2010
复制标题
DOI：
10.1016/j.canep.2016.02.007
复制
发表时间：
2016-06-01
影响因子：
2.6
通讯作者：
Rothman, Nathaniel
中科院分区：
文献类型：
--
作者：
Bassig, Bryan A.;Au, Wing-Yan;Rothman, Nathaniel
对淋巴系统恶性肿瘤(LMS)的临床研究表明，与西方人群相比，东亚地区LMS的描述模式不同。然而，在东亚人群中，特别是在中国人中，关于基于人群的、特定亚型的LMS发病率的可用数据非常有限。使用香港(香港)癌症资料中心和美国(美国)的数据根据SEER计划，我们计算并比较了香港与居住在美国的白人和亚洲人的LM亚型的年龄调整发病率。计算了2001-2010年间的总体发病率和性别特异性发病率。在香港人口中，大多数亚型的发病率都很低，
Clinical studies of lymphoid malignancies (LMs) have suggested that the descriptive patterns of LMs differ in East Asia compared to Western populations. However, there are very limited available data on population-based, subtype-specific incidence rates of LMs in the East Asian population, particularly in Chinese. Using data from the Hong Kong (HK) Cancer Registry and United States (U.S.) SEER Program, we calculated and compared age-adjusted incidence rates of LM subtypes in HK to those in Whites and Asians living in the U.S. Overall and sex-specific rates were calculated for the period 2001-2010. The incidence of most subtypes was low in the HK population, with rates